|
Originally published In Press as doi:10.1074/jbc.M413815200 on May 18, 2005
J. Biol. Chem., Vol. 280, Issue 28, 26622-26629, July 15, 2005
Inefficient Maturation of the Rat Luteinizing Hormone Receptor
A PUTATIVE WAY TO REGULATE RECEPTOR NUMBERS AT THE CELL SURFACE*
E. Maritta Pietilä ,
Jussi T. Tuusa ,
Pirjo M. Apaja ,
Jyrki T. Aatsinki ,
Anna E. Hakalahti ,
Hannu J. Rajaniemi , and
Ulla E. Petäjä-Repo ¶
From the
Biocenter Oulu and Department of Anatomy and Cell Biology and the Department of Anatomy and Cell Biology, University of Oulu, FI-90014, Oulu, Finland
Increasing evidence suggests that the folding and maturation of monomeric proteins and assembly of multimeric protein complexes in the endoplasmic reticulum (ER) may be inefficient not only for mutants that carry changes in the primary structure but also for wild type proteins. In the present study, we demonstrate that the rat luteinizing hormone receptor, a G protein-coupled receptor, is one of these proteins that matures inefficiently and appears to be very prone to premature degradation. A substantial portion of the receptors in stably transfected human embryonic kidney 293 cells existed in immature form of Mr 73,000, containing high mannose-type N-linked glycans. In metabolic pulse-chase studies, only 20% of these receptor precursors were found to gain hormone binding ability and matured to a form of Mr 90,000, containing bi- and multiantennary sialylated N-linked glycans. The rest had a propensity to form disulfide-bonded complexes with a Mr 120,000 protein in the ER membrane and were eventually targeted for degradation in proteasomes. The number of membrane-bound receptor precursors increased when proteasomal degradation was inhibited, and no cytosolic receptor forms were detected, suggesting that retrotranslocation of the misfolded/incompletely folded receptors is tightly coupled to proteasomal function. Furthermore, a proteasomal blockade was found to increase the number of receptors that were capable of hormone binding. Thus, these results raise the interesting possibility that luteinizing hormone receptor expression at the cell surface may be controlled at the ER level by regulating the number of newly synthesized proteins that will mature and escape the ER quality control and premature degradation.
Received for publication, December 8, 2004
, and in revised form, May 2, 2005.
* This work was supported by the Biocenter Oulu and a grant (200732) from the Academy of Finland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ A research fellow of the Academy of Finland. To whom correspondence should be addressed: Dept. of Anatomy and Cell Biology, University of Oulu, P.O. Box 5000, FI-90014, Oulu, Finland. Tel.: 358-8-537-5193; Fax: 358-8-537-5172; E-mail: Ulla.Petaja-Repo{at}oulu.fi.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Janovick, A. Patny, R. Mosley, M. T. Goulet, M. D. Altman, T. S. Rush III, A. Cornea, and P. M. Conn
Molecular Mechanism of Action of Pharmacoperone Rescue of Misrouted GPCR Mutants: The GnRH Receptor
Mol. Endocrinol.,
February 1, 2009;
23(2):
157 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. H. Markkanen and U. E. Petaja-Repo
N-Glycan-mediated Quality Control in the Endoplasmic Reticulum Is Required for the Expression of Correctly Folded {delta}-Opioid Receptors at the Cell Surface
J. Biol. Chem.,
October 24, 2008;
283(43):
29086 - 29098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Schwieger, K. Lautz, E. Krause, W. Rosenthal, B. Wiesner, and R. Hermosilla
Derlin-1 and p97/Valosin-Containing Protein Mediate the Endoplasmic Reticulum-Associated Degradation of Human V2 Vasopressin Receptors
Mol. Pharmacol.,
March 1, 2008;
73(3):
697 - 708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Conn, A. Ulloa-Aguirre, J. Ito, and J. A. Janovick
G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo
Pharmacol. Rev.,
September 1, 2007;
59(3):
225 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. T. Leskela, P. M. H. Markkanen, E. M. Pietila, J. T. Tuusa, and U. E. Petaja-Repo
Opioid Receptor Pharmacological Chaperones Act by Binding and Stabilizing Newly Synthesized Receptors in the Endoplasmic Reticulum
J. Biol. Chem.,
August 10, 2007;
282(32):
23171 - 23183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Lopez-Gimenez, M. Canals, J. D. Pediani, and G. Milligan
The {alpha}1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization Is Required for Receptor Maturation, Surface Delivery, and Function
Mol. Pharmacol.,
April 1, 2007;
71(4):
1015 - 1029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kern, A. I. Agoulnik, and G. D. Bryant-Greenwood
The Low-Density Lipoprotein Class A Module of the Relaxin Receptor (Leucine-Rich Repeat Containing G-Protein Coupled Receptor 7): Its Role in Signaling and Trafficking to the Cell Membrane
Endocrinology,
March 1, 2007;
148(3):
1181 - 1194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Conn, P. E. Knollman, S. P. Brothers, and J. A. Janovick
Protein Folding as Posttranslational Regulation: Evolution of a Mechanism for Controlled Plasma Membrane Expression of a G Protein-Coupled Receptor
Mol. Endocrinol.,
December 1, 2006;
20(12):
3035 - 3041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P M. Conn, J. A. Janovick, S. P Brothers, and P. E Knollman
'Effective inefficiency': cellular control of protein trafficking as a mechanism of post-translational regulation.
J. Endocrinol.,
July 1, 2006;
190(1):
13 - 16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Canals, L. Jenkins, E. Kellett, and G. Milligan
Up-regulation of the Angiotensin II Type 1 Receptor by the MAS Proto-oncogene Is Due to Constitutive Activation of Gq/G11 by MAS
J. Biol. Chem.,
June 16, 2006;
281(24):
16757 - 16767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. E. Petaja-Repo, M. Hogue, T. T. Leskela, P. M. H. Markkanen, J. T. Tuusa, and M. Bouvier
Distinct Subcellular Localization for Constitutive and Agonist-modulated Palmitoylation of the Human {delta} Opioid Receptor
J. Biol. Chem.,
June 9, 2006;
281(23):
15780 - 15789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Apaja, J. T. Tuusa, E. M. Pietila, H. J. Rajaniemi, and U. E. Petaja-Repo
Luteinizing Hormone Receptor Ectodomain Splice Variant Misroutes the Full-Length Receptor into a Subcompartment of the Endoplasmic Reticulum
Mol. Biol. Cell,
May 1, 2006;
17(5):
2243 - 2255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Fortin, E. K. Dziadulewicz, L. Gera, and F. Marceau
A Nonpeptide Antagonist Reveals a Highly Glycosylated State of the Rabbit Kinin B1 Receptor
Mol. Pharmacol.,
April 1, 2006;
69(4):
1146 - 1157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Janovick, P. E. Knollman, S. P. Brothers, R. Ayala-Yanez, A. S. Aziz, and P. M. Conn
Regulation of G Protein-coupled Receptor Trafficking by Inefficient Plasma Membrane Expression: MOLECULAR BASIS OF AN EVOLVED STRATEGY
J. Biol. Chem.,
March 31, 2006;
281(13):
8417 - 8425.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|